Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2022

Alnajar H, Ravichandran H, Rendeiro AF, Ohara K, Zoughbi WA, Manohar J, et al. Tumor-immune microenvironment revealed by Imaging Mass Cytometry in a metastatic sarcomatoid urothelial carcinoma with a prolonged response to pembrolizumab. Cold Spring Harb Mol Case Stud. 2022;8(3).

Lebowitz E, Kim JS, Magro C. Reactive arthritis following COVID-19 vaccination with BNT162b2. JAAD Case Rep. 2022;24:108-111.

Yuen CA, Hsu J-, Van Besien K, Reshef R, Iwamoto FM, Haggiagi A, et al. Axicabtagene Ciloleucel in Patients Ineligible for ZUMA-1 Because of CNS Involvement and/or HIV: A Multicenter Experience. J Immunother. 2022;45(5):254-262.

de Leval L, Alizadeh AA, P Bergsagel L, Campo E, Davies A, Dogan A, et al. Genomic profiling for clinical decision making in lymphoid neoplasms. Blood. 2022;140(21):2193-2227.

Xia Y, Inoue K, Du Y, Baker SJ, E Reddy P, Greenblatt MB, et al. TGFβ reprograms TNF stimulation of macrophages towards a non-canonical pathway driving inflammatory osteoclastogenesis. Nat Commun. 2022;13(1):3920.

Oh C-, Dolatabadi N, Cieplak P, Diaz-Meco MT, Moscat J, Nolan JP, et al. S-Nitrosylation of p62 Inhibits Autophagic Flux to Promote α-Synuclein Secretion and Spread in Parkinson's Disease and Lewy Body Dementia. J Neurosci. 2022;42(14):3011-3024.

Hanel W, Lata P, Youssef Y, Tran H, Tsyba L, Sehgal L, et al. A sumoylation program is essential for maintaining the mitotic fidelity in proliferating mantle cell lymphoma cells. Exp Hematol Oncol. 2022;11(1):40.

Rivera-Cruz G, Boyraz B, Petrozza JC. Reply of the Authors: The Waldo of fibroids under the microscope: fumarate hydratase-deficient leiomyomata. F S Rep. 2022;3(2):174.

Morelli E, Fulciniti M, Samur MK, Ribeiro C, Wert-Lamas L, Henninger JE, et al. A MIR17HG-derived Long Noncoding RNA Provides an Essential Chromatin Scaffold for Protein Interaction and Myeloma Growth. Blood. 2022.

Jang J-, Hwang I, Pan H, Yao J, Alinari L, Imada E, et al. A FOXO1-dependent transcription network is a targetable vulnerability of mantle cell lymphomas. J Clin Invest. 2022;132(24).